News Vir Biotechnology Announces New Clinical Data From its Broad Hepatitis B Program Continue Reading Previous Arbutus Presents New Data on AB-729, AB-836 and AB-101 at the EASL International Liver Congress™ 2022 and Provides AB-836 Clinical UpdateNext Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™ Related Stories News Imagen Network (IMAGE) Taps Grok AI to Power Scalable Personalization in Decentralized Social Systems News Clara Technologies Secures 14-Month Development Agreement to Advance Quantum-Enabled Sales Buddi News Soleeva Launches Initiative to Facilitate State-Funded Solar and Battery Storage for Low-Income Households News Top 10 U.S. States & Cities for Solopreneurs to Maximize Profits in 2025, According to DesignRush News CEO.CA’s Inside the Boardroom: Catalysts That Are Expected for the Remainder of 2025 Leading up to a Construction Decision in 2026 News CEO.CA’s Inside the Boardroom: Sterling Metals Hits Porphyry Copper in Final Three Holes at Soo Copper Project
